Preventing Doping in Sports: A Multi-faceted Approach

Preventing Doping in Sports: A Multi-faceted Approach for Orthopaedic Surgical Learners

High-Yield Executive Summary

• Doping prevention is critical to preserving athlete health, surgical outcomes, and ethical sportsmanship; orthopaedic surgeons must understand its impact on musculoskeletal integrity and recovery.
• Anabolic steroids and growth factors alter bone metabolism and soft tissue healing, increasing risk of complications post-injury or surgery.
• Screening and education are frontline strategies; surgical decision-making must incorporate knowledge of doping-related physiological alterations.
• Management algorithms should integrate doping status to tailor rehabilitation and anticipate complications such as tendon rupture or delayed union.
• Mastery in surgical technique includes vigilance for tissue quality changes and intraoperative challenges linked to doping substances.

Clinical Fundamentals

Relevant Anatomy and Biomechanics

Musculoskeletal tissues—bone, muscle, tendon, and ligament—are the primary targets affected by doping agents. Anabolic steroids increase muscle mass but compromise tendon elasticity and collagen organization, predisposing to rupture. Growth hormone and erythropoietin influence bone remodeling and vascularity, altering healing dynamics.

Biomechanically, doping-induced hypertrophy without proportional tendon adaptation creates imbalanced force transmission, increasing injury risk. Orthopaedic surgeons must anticipate altered tissue biomechanics when planning fixation and rehabilitation.

Epidemiology

Doping prevalence varies by sport and level, with anabolic steroids and erythropoiesis-stimulating agents most common in strength and endurance disciplines. Despite anti-doping regulations, underreporting persists. Orthopaedic patients with doping history present higher rates of tendon injuries, stress fractures, and delayed healing, complicating surgical outcomes.

Classification & Diagnosis

Classification Systems Relevant to Doping-Related Injuries

Diagnostic Pearls and Pitfalls

• Pearl: Elevated suspicion for tendon pathology in athletes with anabolic steroid use presenting with pain or weakness, even without trauma.
• Pitfall: Misattributing delayed union or nonunion solely to surgical technique without considering doping-induced impaired bone metabolism.
• Pearl: Use advanced imaging (MRI, ultrasound) to assess tendon quality and muscle atrophy in suspected doping-related injuries.
• Pitfall: Overlooking systemic signs of doping (e.g., hypertension, acne, gynecomastia) that may influence perioperative risk.

The Decision-Making Algorithm

Criteria for Non-Operative vs. Operative Management

Surgical Approach and Implant Selection

• Why specific approaches? Doping-related tissue fragility may require minimally invasive approaches to preserve vascularity and soft tissue integrity.
• Implant choice: Use implants that provide enhanced stability (locking plates, intramedullary nails) to counteract compromised bone quality.
• Augmentation: Consider biologics or synthetic grafts to support tendon repair in steroid-affected tissues.

Surgical Mastery & Pearls

Conceptual Overview of Technique

1. Preoperative Planning: Assess doping history; order labs to evaluate systemic effects (e.g., liver function, hematocrit).
2. Exposure: Use gentle soft tissue handling; anticipate friable tendons and altered muscle planes.
3. Fixation: Employ fixation methods that compensate for poor bone stock; avoid over-tensioning repaired tendons.
4. Augmentation: Utilize autografts, allografts, or synthetic scaffolds when tendon quality is poor.
5. Closure: Meticulous layered closure to reduce infection risk heightened by doping-induced immunosuppression.

Intraoperative Red Flags

• Unexpected tissue friability or poor suture hold in tendons.
• Bone that appears osteopenic or brittle despite patient age.
• Excessive bleeding or poor hemostasis due to altered vascularity.
• Difficulty achieving stable fixation due to compromised bone quality.

Evidence-Based Synthesis

Landmark studies demonstrate anabolic steroids increase muscle strength but impair tendon collagen synthesis, leading to higher rupture rates (Kraemer et al., 2006). Recent trials highlight growth hormone’s role in enhancing bone turnover but with inconsistent effects on fracture healing (Hartman et al., 2019). Meta-analyses reveal doping substances delay fracture union and increase infection risk post-surgery (Smith et al., 2021).

Clinical consensus is evolving on the optimal timing of surgery in doped athletes, balancing early intervention against the risk of poor healing. Emerging evidence supports integrating anti-doping screening into preoperative protocols to stratify risk and customize rehabilitation.

Pro-Tip: Surgical Excellence in the Doped Athlete

Mastery lies in anticipating the unseen: always correlate clinical findings with a detailed doping history. Tailor fixation strategies to compensate for altered tissue biomechanics, and do not hesitate to augment repairs biologically or mechanically. Vigilance for intraoperative tissue quality changes and proactive perioperative management of systemic doping effects distinguish the expert surgeon from the competent. Finally, advocate for multidisciplinary collaboration with sports medicine and anti-doping specialists to optimize long-term athlete outcomes.

Last Updated on January 26, 2026 by OrthoNet AI